Volume 5 Number 1 2026
Scalable Microfluidic Manufacturing of Theranostic Liposomes: Batch Consistency and GMP-Ready Process Design
Tina Thai 1*
Biosensors and Nanotheranostics 5 (1) 1-8 https://doi.org/10.25163/biosensors.5110973
Submitted: 21 July 2026 Revised: 12 September 2026 Accepted: 22 September 2026 Published: 24 September 2026
Theranostic liposomes carry a drug and an imaging agent in the same particle, so that treatment and the means of watching it arrive together. Few have reached patients, and the obstacle is more often manufacturing than biology. Conventional bulk routes — thin-film hydration, ethanol injection, high-pressure homogenisation — rely on turbulent mixing in which nucleation conditions vary from one region of the vessel to the next. The products are correspondingly uneven: diameters of roughly 120–200 nm, polydispersity above 0.25, modest entrapment of hydrophilic contrast agents, and a drift between lots that regulators are unlikely to overlook. This review asks how far microfluidic continuous-flow manufacturing closes that gap. Drawing on twelve verified sources published between 2013 and 2026, we compare hydrodynamic flow focusing, staggered herringbone, Dean-flow and active micromixers, relating their operating variables — chiefly total flow rate and flow rate ratio — to the attributes that matter for release. A consistent picture emerges. Millisecond laminar mixing yielded vesicles of about 30–120 nm with polydispersity below 0.10–0.20 and encapsulation of roughly 70–95%, across payloads as different as a hydrogel core holding iopamidol and doxorubicin, indocyanine green J-aggregates stabilised within a rigid bilayer, cRGD-targeted gadolinium liposomes, and exosome-wrapped cubosomes assembled by low-shear fusion. Replicating channels rather than accelerating one raised throughput more than a hundredfold without altering particle quality. What remains unsettled is the translational half: anti-PEG immunity, protein-corona masking of ligands, uneven EPR-dependent delivery, and the regulatory status of drug–imaging combinations. We close with a Quality-by-Design framework linking device choice to process analytics and release criteria.
Keywords: theranostic liposomes; microfluidics; continuous manufacturing; Quality-by-Design; process analytical technology; batch-to-batch consistency; Good Manufacturing Practice; nanomedicine scale-up
Alotaibi, H., Hatahet, T., & Al-Jamal, W. T. (2025). Stabilising indocyanine green J-aggregate theranostics in biological milieu via liposomal envelopment. European Journal of Pharmaceutics and Biopharmaceutics, 213, Article 114747. https://doi.org/10.1016/j.ejpb.2025.114747
Balbino, T. A., Aoki, N. T., Gasperini, A. A. M., Oliveira, C. L. P., Azzoni, A. R., Cavalcanti, L. P., & de la Torre, L. G. (2013). Continuous flow production of cationic liposomes at high lipid concentration in microfluidic devices for gene delivery applications. Chemical Engineering Journal, 226, 423–433. https://doi.org/10.1016/j.cej.2013.04.059
Cunha, J., Latocheski, E., Fidalgo, A. C. D., Gerola, A. P., Marin, C. F. F., & Ribeiro, A. J. (2025). Core-shell hybrid liposomes: Transforming imaging diagnostics and therapeutic strategies. Colloids and Surfaces B: Biointerfaces, 251, Article 114597. https://doi.org/10.1016/j.colsurfb.2025.114597
Jürgens, D. C., Deßloch, L., Porras-Gonzalez, D., Winkeljann, J., Zielinski, S., Munschauer, M., Hörner, A. L., Burgstaller, G., Winkeljann, B., & Merkel, O. M. (2023). Lab-scale siRNA and mRNA LNP manufacturing by various microfluidic mixing techniques: An evaluation of particle properties and efficiency. OpenNano, 12, Article 100161. https://doi.org/10.1016/j.onano.2023.100161
Lee, S. M., Yoo, S. Y., Kim, T., Kim, N., Kang, J. H., Lim, K. Y., Kim, M., Choo, S., Lee, H. S., Kim, H., Kang, N. W., Chaudhary, M., Bikram, K., Lee, W., Cho, C. W., Kim, D. D., Kim, K. T., & Lee, J. Y. (2025). Radiopaque hydrogel-in-liposomes towards theranostic applications for malignant tumors. Biomedicine & Pharmacotherapy, 183, Article 117822. https://doi.org/10.1016/j.biopha.2025.117822
Maeki, M., Fujishima, Y., Sato, Y., Yasui, T., Kaji, N., Ishida, A., Tani, H., Baba, Y., Harashima, H., & Tokeshi, M. (2017). Understanding the formation mechanism of lipid nanoparticles in microfluidic devices with chaotic micromixers. PLoS ONE, 12(11), Article e0187962. https://doi.org/10.1371/journal.pone.0187962
Modarres, P., & Tabrizian, M. (2020). Electrohydrodynamic-driven micromixing for the synthesis of highly monodisperse nanoscale liposomes. ACS Applied Nano Materials, 3(5), 4000–4013. https://doi.org/10.1021/acsanm.0c00227
Ovejero-Paredes, K., Bisbano, G., Flier, I., González-Simón, A., Marciello, M., Oliveira, S., Zupi, M., Rubes, D., Ayash, F., Doria, F., Pirota, V., Terreni, M., Serra, M., & Filice, M. (2025). Microfluidic-assisted synthesis of integrin-targeting cRGD liposomes as a scalable strategy for theranostic applications in triple-negative breast cancer. European Journal of Pharmaceutical Sciences, 213, Article 107216. https://doi.org/10.1016/j.ejps.2025.107216
Prakash, G., Shokr, A., Willemen, N., Bashir, S. M., Shin, S. R., & Hassan, S. (2022). Microfluidic fabrication of lipid nanoparticles for the delivery of nucleic acids. Advanced Drug Delivery Reviews, 184, Article 114197. https://doi.org/10.1016/j.addr.2022.114197
Shahsavari, S., Rad, M. B., Hajiaghajani, A., Rostami, M., Hakimian, F., Jafarzadeh, S., Hasany, M., Collingwood, J. F., Aliakbari, F., Fouladiha, H., Bardania, H., Otzen, D. E., & Morshedi, D. (2024). Magnetoresponsive liposomes applications in nanomedicine: A comprehensive review. Biomedicine & Pharmacotherapy, 181, Article 117665. https://doi.org/10.1016/j.biopha.2024.117665
Shepherd, S. J., Warzecha, C. C., Yadavali, S., El-Mayta, R., Alameh, M. G., Wang, L., Weissman, D., Wilson, J. M., Issadore, D., & Mitchell, M. J. (2021). Scalable mRNA and siRNA lipid nanoparticle production using a parallelized microfluidic device. Nano Letters, 21(13), 5671–5680. https://doi.org/10.1021/acs.nanolett.1c01353
Wu, F., Shen, Y., Dong, L., Nie, W., & Xue, W. (2026). A membrane-fused theranostic nanoplatform for real-time ROS imaging and mitochondrial resuscitation-driven barrier repair in acute kidney injury. Materials Today Bio, 38, Article 103217. https://doi.org/10.1016/j.mtbio.2026.103217
Stimuli-Responsive Nanocarriers Reprogram the Rheumatoid Joint but Outpace Clinical Manufacturing